Tag: Obesity
Phenomix Sciences Announces First Obesity Biobank Registry to Study Underlying Phenotypes
On a mission to conquer obesity, Phenomix Sciences has launched its first obesity biobanking registry and outcomes study. The registry will study variability in obesity by looking at genetic and environmental factors in patients, and analyze interventions that will...
A Population-Based Prospective Study to Establish an Link Between Body Composition and Gastric Cancer
Gastric cancer is one of the most common and deadly cancers worldwide. Data from the GLOBOCAN database showed that gastric cancer was responsible for over 1,033,000 new cases and 78,200 deaths in 2018, ranking fifth for cancer incidence and...
Utilizing Biobank Data to Correlate Adiposity with Cancer Incidence and Mortality
Obesity has strong association with increased incidence of, and premature mortality from, some types of cancer1. However, a study by the World Cancer Research Fund (WCRF) report also highlighted the lack of evidence regarding the association of cancer with...
Free Testing Program For Rare Genetic Disorders Of Obesity Launched By Rhythm Pharmaceuticals
Rhythm Pharmaceuticals, Inc., a biopharmaceutical company
focused on the development and commercialization of therapeutics for the
treatment of rare genetic disorders of obesity, today announced the launch of
Uncovering Rare Obesity, a free genetic testing program that may help determine
if individuals have...
Biobanking Science: Treating Obesity With Intermittent Fasting
Obesity has reached epidemic proportions. Over 1.9 billion adults and 380 million children are now overweight or obese (1). These people are more likely to suffer from chronic life-threatening diseases such as heart disease, stroke, diabetes and cancer (1)....
